According to a new report, published by KBV research, The Global Protein Expression Market size is expected to reach $4.9 billion by 2028, rising at a market growth of 10.1% CAGR during the forecast period.
The Prokaryotic market has acquired the maximum revenue share in the Global Protein Expression Market by System in 2021, thereby, achieving a market value of $1.9 billion by 2028. The prokaryotic is generally simpler to handle and serves important functions in research. Due to its positive traits, including its ability to produce large quantities of recombinant proteins quickly and inexpensively, the market is expected to grow further over the forecast period.
The Competent Cells market is showcasing a CAGR of 9.8% during (2022 - 2028). Some common competent cells are manufactured and sold commercially, which has boosted the segment's growth. In addition, certain competent cells are BL21 (DE3) pLysS competent cells that could be utilized for both dangerous and nontoxic proteins, and, BL21 (DE3) competent cells, which are used for nontoxic proteins.
The Therapeutic market has generated the highest share in the Global Protein Expression Market by Application in 2021, thereby, achieving a market value of $2.4 billion by 2028. They can be tailored, which leads to a more successful course of therapy and a low risk of side effects. Additionally, it can serve as replacement therapy when a gene defect prevents the body from producing enough functional proteins.
The Academic Research market has shown the high growth rate of 10.4% during (2022 - 2028). Protein expression is a crucial tool in biomedical research and is becoming more significant as a pharmaceutical manufacturing process for biological therapies. The degree of influence researchers has over the finished product heavily influences their capacity to influence how proteins will ultimately behave.
The North America market dominated the Global Protein Expression Market by Region in 2021, thereby, achieving a market value of $1.8 billion by 2028. The Europe market is experiencing a CAGR of 9.8% during (2022 - 2028). Additionally, The Asia Pacific market would exhibit a CAGR of 10.9% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/protein-expression-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Merck Group, New England BioLabs, Inc., Promega Corporation, Qiagen N.V., Takara Bio, Inc. (Takara Holdings Inc.), Oxford Expression Technologies Ltd., and LGC Biosearch Technologies.
By System
By Product
By Application
By End User
By Geography
Companies Profiled
Unique Offerings 
